StepStone Group’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-826,569
| Closed | -$1.64M | – | 18 |
|
|
2025
Q2 | $1.64M | Hold |
826,569
| – | – | 3.26% | 7 |
|
|
2025
Q1 | $1.2M | Hold |
826,569
| – | – | 1.23% | 10 |
|
|
2024
Q4 | $1.71M | Hold |
826,569
| – | – | 1.5% | 9 |
|
|
2024
Q3 | $1.45M | Hold |
826,569
| – | – | 0.53% | 11 |
|
|
2024
Q2 | $12M | Hold |
826,569
| – | – | 2.42% | 7 |
|
|
2024
Q1 | $13.7M | Hold |
826,569
| – | – | 2.91% | 7 |
|
|
2023
Q4 | $13.3M | Buy |
826,569
+2
| +0% | +$27 | 2.39% | 7 |
|
|
2023
Q3 | $11.1M | Buy |
826,567
+149,998
| +22% | +$2.11M | 2.48% | 8 |
|
|
2023
Q2 | $11.6M | Hold |
676,569
| – | – | 2.15% | 6 |
|
|
2023
Q1 | $11.2M | Buy |
676,569
+2
| +0% | +$32 | 2.08% | 6 |
|
|
2022
Q4 | $11.3M | Hold |
676,567
| – | – | 1.48% | 10 |
|
|
2022
Q3 | $11.6M | Hold |
676,567
| – | – | 1.64% | 11 |
|
|
2022
Q2 | $7.39M | Buy |
+676,567
| New | +$8.03M | 0.79% | 16 |
|
StepStone Group's HLVX Position: Q3 2025 in Review
StepStone Group sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 826,569 shares — an estimated $1.64M sold.
StepStone Group first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $13.7M in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- StepStone Group reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- StepStone Group sold 826,569 HilleVax shares in Q3 2025, an estimated $1.64M.
- StepStone Group first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
- StepStone Group's HilleVax position peaked at $13.7M in Q1 2024.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on StepStone Group's 13F filing for Q3 2025, filed 14 Nov 2025.